One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others.

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others. A study published in Nature Communications, by a multidisciplinary team ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that preclinical data from its IL ...

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others. A study published in ...

AI Foundation Models Accelerate Oncology Drug Development Pipeline and Optimize Probability of Technical SuccessWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of the leading AI foundation ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. For decades, the "gut-kidney axis" hypothesis has suggested that the ...

Cellular senescence, a state characterized by stable cell cycle arrest, has emerged as a critical process in maintaining tissue homeostasis by limiting the ...

Bone remodeling is a dynamic and tightly regulated process that maintains skeletal integrity throughout life. Central to this process are osteoclasts, the ...

Researchers identify a gene expression program in the living human brain that tracks with real-time neurotransmission, bridging the gap between genetics and electrical brain activity.